Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AVTX-002 for poorly controlled non-eosinophilic asthma has completed, with results posted on 2024-09-05.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-eosinophilic Asthma

Drugs mentioned

• AVTX-002

Snippet

Sponsor: Avalo Therapeutics, Inc. | Conditions: Non-Eosinophilic Asthma | Phase 2 | Status: COMPLETED | Results posted: 2024-09-05